Skip to main content
Annals of Dermatology logoLink to Annals of Dermatology
. 2025 Sep 4;37(6):357–362. doi: 10.5021/ad.25.104

Perceptions and Experiences of Scalp Micropigmentation Among Dermatology Outpatients With Hair Loss: A Survey-Based Study

Myeong Jae Kim 1,2, Hei Sung Kim 2,✉
PMCID: PMC12715880  PMID: 41331716

Abstract

Background

Scalp micropigmentation (SMP) is a non-surgical procedure used to camouflage hair loss or scalp scars. Although SMP is legally permitted only when performed by licensed medical professionals in South Korea, it is frequently administered in non-medical settings, raising safety and regulatory concerns.

Objective

This study aimed to evaluate the awareness, perceptions, legal knowledge, treatment experiences, and provider preferences related to SMP among dermatology outpatients with alopecia in South Korea.

Methods

A structured 13-item questionnaire was administered to 131 adult dermatology outpatients with hair loss at Incheon St. Mary’s Hospital. The survey assessed participants' awareness of SMP, sources of information, willingness to undergo the procedure, legal knowledge, and previous experiences.

Results

Among the respondents, 90.8% had heard of SMP, most commonly through the Internet or family and friends. A majority (65.6%) were aware that SMP is legally restricted to licensed medical professionals. However, all five participants (3.8%) who had undergone SMP received the procedure in non-medical settings. Notably, 82.5% of participants without prior SMP experience preferred medically supervised settings, and all individuals with prior SMP experience indicated they would choose a hospital for future procedures.

Conclusion

This study reveals a disconnect between legal awareness and actual treatment behavior regarding SMP. While most patients understand that SMP is a medical procedure requiring physician oversight, many still receive treatment in non-medical environments. The findings highlight the need to expand access to physician-led SMP services, enhance public education, and reinforce regulatory enforcement to ensure patient safety and align practices with clinical standards.

Keywords: Awareness, Legislation as Topic, Perception, Scalp, Surveys and questionnaires, Tattooing

INTRODUCTION

Hair loss, which can result from a wide range of underlying conditions, is a highly visible issue that can significantly impact an individual’s quality of life1,2,3,4. In response, many individuals turn to cosmetic solutions such as wigs, hair concealers, or hair transplantation5. However, each option has limitations: wigs may be uncomfortable and impractical for daily wear; concealers provide only temporary coverage and are prone to smudging when exposed to moisture; and hair transplantation is often costly and unsuitable for individuals with limited donor hair or surgical anxiety5,6,7,8.

Scalp micropigmentation (SMP) has emerged as a relatively simple, non-surgical alternative. This technique involves implanting pigments into the scalp in a stippling pattern to replicate the appearance of closely cropped hair7,9,10.

SMP is fundamentally a medical procedure that requires specialized training and clinical expertise. Achieving optimal outcomes depends on a comprehensive pre-procedural evaluation by a qualified physician which includes accurate diagnosis, assessment of the patient’s medical history, prior treatments, and evaluation of the underlying type and progression of alopecia. Such evaluation is essential for determining the appropriate indication and timing of the procedure, selecting the correct technique, ensuring proper post-procedural care, and managing the underlying hair loss condition over time.

Accordingly, in South Korea, the Medical Service Act mandates that procedures like tattooing and semi-permanent makeup—including SMP—must be performed exclusively by licensed medical professionals11.

Despite this legal requirement, SMP is still frequently performed in non-medical environment such as tattoo studios and beauty salons, rather than in clinical settings12. Procedures conducted by unqualified providers may result in complications including inappropriate patient selection, pigment migration, unnatural cosmetic outcomes, or skin damage—issues that are often difficult and expensive to correct11,12,13.

In light of these legal and safety concerns, it is important to examine both public awareness and real-world treatment practices surrounding SMP. While prior studies have mainly focused on technical or cosmetic outcomes, little attention has been given to patient perceptions or the qualifications of SMP providers. This study surveyed dermatology outpatients with alopecia to evaluate their awareness of SMP, willingness to undergo the procedure, understanding of its legal status, and prior treatment experiences. The findings aim to clarify current perceptions and practices surrounding SMP in South Korea and to identify unmet patient needs and concerns regarding its use.

MATERIALS AND METHODS

This survey-based study was conducted among 131 adult dermatology outpatients (aged ≥18 years) presenting with hair loss at Incheon St. Mary’s Hospital, The Catholic University of Korea. Participants were recruited during routine outpatient visits and were informed of the study’s purpose before participating in the survey. The study was approved by the Institutional Review Board (IRB) of Incheon St. Mary’s Hospital (IRB Number: OC23QISI0015).

A structured, self-administered questionnaire comprising 13 items was used to assess participants’ awareness, perceptions, and experiences related to SMP. The questionnaire included both multiple-choice and short-answer formats. Questions 5 through 13 were designated for individuals with prior SMP experience. The complete questionnaire is available in Supplementary Data 1.

RESULTS

Participant characteristics

Among the 131 survey respondents, 93 (71.0%) were female and 38 (29.0%) were male. Participants ranged in age from their 20s to 70s and older, with the largest age group being individuals in their 50s (29.8%), followed by those in their 40s (26.7%) and 60s (16.8%). Detailed age and sex distribution are detailed in Fig. 1 and Supplementary Fig. 1.

Fig. 1. Age and sex distribution of the 131 survey respondents.

Fig. 1

Hair loss types were clinically classified for 121 of the 131 respondents, based on scarring versus non-scarring categories. As shown in Table 1, non-scarring alopecia was more common, with alopecia areata (46.3%), female pattern hair loss (24.8%), and androgenetic alopecia (20.7%) being the most frequently reported types.

Table 1. Distribution of hair loss types among 121 survey respondents.

Variables Values
Non-scarring alopecia
Alopecia areata 56 (46.3)
Female pattern hair loss 30 (24.8)
Androgenetic alopecia 25 (20.7)
Telogen effluvium 5 (4.1)
Anagen effluvium (chemotherapy-induced) 3 (2.5)
Scarring alopecia
Scarring alopecia 2 (1.7)

Values are presented as number (%).

Awareness of SMP and sources of information

A total of 119 participants (90.8%) reported being aware of SMP. The most common sources of information included the Internet (45.8%), family or friends (24.4%), and hair or nail salons (Fig. 2A).

Fig. 2. Awareness and willingness related to SMP. (A) Awareness of SMP and initial source of information, (B) prior experience, (C) intention among non-recipients, (D) preferred setting for future SMP procedures.

Fig. 2

SMP: scalp micropigmentation.

Prior experience with SMP and willingness to undergo the procedure

Only 5 respondents (3.8%) had previously undergone SMP (Fig. 2B). Among the remaining 126 participants without prior experience, 13 (10.3%) indicated that they had seriously considered the procedure (Fig. 2C). When asked about preferred setting for SMP, the majority (82.5%) selected hospitals or medical institutions, followed by tattoo studios (13.5%) (Fig. 2D).

Awareness of legal regulations

Overall, 86 participants (65.6%) were aware that SMP is legally restricted to medical professionals in South Korea, while 45 (34.4%) were unaware of this regulation (Fig. 3). Notably 2 of the 5 individuals with who had received SMP were unaware of the legal restrictions at the time of their procedure (Supplementary Fig. 2).

Fig. 3. Legal awareness of tattooing and semi-permanent procedures performed outside medical institutions.

Fig. 3

Characteristics of SMP recipients

The 5 respondents who reported undergoing SMP were asked additional questions about their experience (Supplementary Table 1). All had received the procedure within the past 10 years, most commonly at a hair salon (n=3, 60.0%) followed by a tattoo studio (n=2, 40.0%).

When asked about the most influential factor in selecting a location for SMP, 3 participants (60.0%) cited recommendations from family or acquaintances, while 2 (40.0%) identified hair salons as the primary influence. Regarding the most important consideration in choosing a provider, three respondents (60.0%) selected “other”. Their written responses included recommendations from acquaintances (n=2) and “demo” session (n=1). The remaining 2 participants (40.0%) prioritized the provider’s design sense and aesthetic skills.

The SMP sites were the forehead (M-shaped recession/ hairline) (20%), the crown (40%), and the occiput (20%). One participant (20.0%) received SMP over the whole scalp.

As for the level of satisfaction with SMP, a participant who received SMP as a demo (free of cost) reported to be satisfied (20%), two were somewhat satisfied (40%), and two dissatisfied (40%). Worsening of hair loss (20%), Change in tattoo shape and color (40%), persistent pain at the SMP site (20%), and other (contact dermatitis after SMP, 20%) were stated as post-procedural complications.

Reported procedure costs ranged from 0 to 2,000,000 Korean won (KRW), with a mean cost of 600,000 KRW (Supplementary Table 2). One respondent underwent SMP free of charge. The maximum amount participants were willing to pay ranged from 200,000 to 3,000,000 KRW, with a mean value of 1,440,000 KRW.

Regarding satisfaction, 1 participant (20.0%) expressed dissatisfaction. Notably, all individuals with prior SMP experience expressed a desire to have it performed in a hospital setting in the future.

DISCUSSION

This study examined dermatology outpatients’ awareness of SMP, willingness to undergo the procedure, knowledge of its legal status, and prior treatment experiences through a hospital-based survey in South Korea.

Among the 131 respondents with hair loss, 90.8% reported being aware of SMP. This aligns with a previous South Korean study involving 601 individuals, in which 52.6% of the participants were familiar with SMP, suggesting a relatively high level of public recognition across various populations14.

However, improvements were observed in participants’ awareness of legal regulations. In the present study, 65.6% correctly recognized that SMP—along with other tattooing and semi-permanent makeup procedures—is legally restricted to licensed medical professionals in South Korea. In contrast, the earlier study found that a significant portion of the general adult population did not regard SMP as a medical procedure14. This difference may be attributable to differences in study populations. While the previous study was conducted on the general public, the current study surveyed dermatology outpatients actively seeking care for hair loss. As individuals receiving medical treatment, these patients may differ from the general population in their perceptions of SMP and may have had greater awareness of its legal status, even if this did not always translate into medically supervised treatment behavior.

Previous research involving 120 participants showed that the vast majority (89.2%) had undergone SMP in non-medical settings such as beauty or nail salons, permanent makeup shops, or tattoo studios12. Similarly, in this study, although only five respondents (3.8%) reported prior SMP experience, all had received the procedure in non-medical environments. These findings underscore a persistent gap between legal standards and real-world practice, highlighting that SMP continues to be performed predominantly outside of medical supervision, despite regulatory restrictions. Possible explanations for this gap can be found in the responses of participants with prior SMP experience. When asked about the most influential source in choosing their treatment location, most cited recommendation from family or acquaintances (60%) or the hair salon (40%). Similarly, when asked which factors they prioritized in choosing a treatment location, participants selected aesthetic elements such as the provider’s design sense & aesthetic skills (40%) or other non-clinical considerations (60%), including recommendations from acquaintances, with no one selecting cost, hygiene, or whether the provider was a medical professional. These findings suggest that social influence and perceived cosmetic skill may play a stronger role in shaping treatment decisions than regulatory or medical considerations, and that such factors could be potential causes of the observed discrepancy between patients’ perceptions and their actual treatment behaviors.

The efficacy of SMP may vary by type of hair loss. In female pattern hair loss (FPHL), where overall density is reduced without hairline recession, SMP helps reduce the “see-through” appearance caused by decreased hair density6. In male pattern baldness (MPB), it provides visual improvement, although there is a potential risk of exposure if hair loss progresses. In cases of scalp scars resulting from various causes, including neurosurgery, head trauma, or hair transplantation, SMP is effective for concealing scars6,7. While clinical efficacy depends on the type of hair loss, cosmetic outcomes can be influenced by technical factors, such as pigment composition. The pigments used for SMP vary by color. Iron oxide is the most frequently used component, particularly for black and brown tones. Titanium dioxide is used for white, cinnabar or mercuric sulfate for red, and cadmium sulfide for yellow11.

Although the current study did not statistically analyze the relationship between tattooed area size and satisfaction, previous studies have reported high satisfaction across a range of treatment areas (e.g., 40.5–270 cm2 for FPHL), suggesting that satisfactory outcomes may be achieved across various spot sizes. However, further research is needed to confirm whether tattooed area size significantly influences patient satisfaction6.

SMP can be a highly effective and well-tolerated procedure when appropriately indicated; however, its safety and efficacy are closely tied to the qualifications and expertise of the provider6,10,15,16,17. Despite its growing popularity as a cosmetic solution for hair loss, the incidence of unsatisfactory outcomes has increased in parallel with rising demand. Given the broad spectrum of underlying causes of hair loss—including both scarring and non-scarring alopecia—accurate diagnosis by a physician is essential12. A thorough clinical evaluation is crucial to determine whether SMP is suitable as a complementary approach or if the underlying condition is better managed with medical therapy. For example, one of our patients underwent SMP across the entire scalp, later diagnosed with alopecia totalis—a condition that significantly improved with janus kinase inhibitor therapy. She subsequently developed scalp pruritus and eczema, highlighting that the SMP procedure had been unnecessary and potentially avoidable with appropriate medical assessment (Fig. 4).

Fig. 4. A patient with alopecia totalis who underwent an unnecessary SMP. (A) SMP over the entire scalp by a non-medical personnel, (B) recovery of hair with janus kinase inhibitors.

Fig. 4

SMP: scalp micropigmentation.

This study has several limitations. First, the number of participants with prior SMP experience was small, limiting the generalizability of findings related to satisfaction and complications. Second, as a single-center survey conducted in a dermatology outpatient clinic, the results may not fully represent awareness or behaviors across the general population. Nonetheless, the study provides important preliminary insights into how SMP is perceived and practiced among dermatology patients in South Korea.

In conclusion, this study highlights a clear disconnect between public awareness of SMP’s legal requirements and actual treatment behaviors. Although many patients recognize that SMP should be performed by licensed medical professionals, the procedure continues to be frequently conducted in non-medical settings, often influenced by personal recommendations or the accessibility of salons and studios. Notably, despite this mismatch between knowledge and practice, there was a strong preference—especially among individuals with prior SMP experience—for receiving the procedure in medically supervised environments. To improve patient safety and align practice with legal and clinical standards, it is essential to expand access to dermatologists-led SMP services.

Footnotes

FUNDING SOURCE: This research was supported by the Chung-Ang University Graduate Research Scholarship in 2023 and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI23C086000 and grant number: RS-2025-02217860).

CONFLICTS OF INTEREST: The authors have nothing to disclose.

DATA SHARING STATEMENT: Data of this article is available from the corresponding author upon reasonable request.

SUPPLEMENTARY MATERIALS

Supplementary Data 1

Full questionnaire on SMP

ad-37-357-s001.doc (903KB, doc)
Supplementary Table 1

Survey responses from participants with prior SMP experience (n=5)

ad-37-357-s002.xls (32.5KB, xls)
Supplementary Table 2

Reported costs and willingness to pay for SMP among recipients (n=5)

ad-37-357-s003.xls (29KB, xls)
Supplementary Fig. 1

Age and sex distribution of the scalp micropigmentation recipients.

ad-37-357-s004.ppt (208.5KB, ppt)
Supplementary Fig. 2

Legal awareness of tattooing and semi-permanent procedures performed outside medical institutions among scalp micropigmentation recipients.

ad-37-357-s005.ppt (217KB, ppt)

References

  • 1.Williamson D, Gonzalez M, Finlay AY. The effect of hair loss on quality of life. J Eur Acad Dermatol Venereol. 2001;15:137–139. doi: 10.1046/j.1468-3083.2001.00229.x. [DOI] [PubMed] [Google Scholar]
  • 2.Hesketh PJ, Batchelor D, Golant M, Lyman GH, Rhodes N, Yardley D. Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches. Support Care Cancer. 2004;12:543–549. doi: 10.1007/s00520-003-0562-5. [DOI] [PubMed] [Google Scholar]
  • 3.Katoulis AC, Christodoulou C, Liakou AI, Kouris A, Korkoliakou P, Kaloudi E, et al. Quality of life and psychosocial impact of scarring and non-scarring alopecia in women. J Dtsch Dermatol Ges. 2015;13:137–141. doi: 10.1111/ddg.12548. [DOI] [PubMed] [Google Scholar]
  • 4.Rencz F, Gulácsi L, Péntek M, Wikonkál N, Baji P, Brodszky V. Alopecia areata and health-related quality of life: a systematic review and meta-analysis. Br J Dermatol. 2016;175:561–571. doi: 10.1111/bjd.14497. [DOI] [PubMed] [Google Scholar]
  • 5.Saed S, Ibrahim O, Bergfeld WF. Hair camouflage: a comprehensive review. Int J Womens Dermatol. 2016;2:122–127. doi: 10.1016/j.ijwd.2016.09.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Park JH, Moh JS, Lee SY, You SH. Micropigmentation: camouflaging scalp alopecia and scars in Korean patients. Aesthetic Plast Surg. 2014;38:199–204. doi: 10.1007/s00266-013-0259-1. [DOI] [PubMed] [Google Scholar]
  • 7.Rassman WR, Pak JP, Kim J, Estrin NF. Scalp micropigmentation: a concealer for hair and scalp deformities. J Clin Aesthet Dermatol. 2015;8:35–42. [PMC free article] [PubMed] [Google Scholar]
  • 8.Park JH, Ho YH, Manonukul K. Natural results of scalp micropigmentation: a review. J Cosmet Dermatol. 2022;21:5509–5513. doi: 10.1111/jocd.15297. [DOI] [PubMed] [Google Scholar]
  • 9.Rassman WR, Pak JP, Kim J. Scalp micropigmentation: a useful treatment for hair loss. Facial Plast Surg Clin North Am. 2013;21:497–503. doi: 10.1016/j.fsc.2013.05.010. [DOI] [PubMed] [Google Scholar]
  • 10.Seyhan T, Kapi E. Scalp micropigmentation procedure: a useful procedure for hair restoration. J Craniofac Surg. 2021;32:1049–1053. doi: 10.1097/SCS.0000000000007208. [DOI] [PubMed] [Google Scholar]
  • 11.Garg G, Thami GP. Micropigmentation: tattooing for medical purposes. Dermatol Surg. 2005;31:928–931. [PubMed] [Google Scholar]
  • 12.Park JH, Kim N, Kim DW, Lee I. Revision for unsatisfactory outcomes of scalp micropigmentation. Int J Dermatol. 2025;64:136–141. doi: 10.1111/ijd.17260. [DOI] [PubMed] [Google Scholar]
  • 13.De Cuyper C. Permanent makeup: indications and complications. Clin Dermatol. 2008;26:30–34. doi: 10.1016/j.clindermatol.2007.10.009. [DOI] [PubMed] [Google Scholar]
  • 14.Lee JA, Lee KH, Yun JH, Kim SJ, Kim ES. Awareness of Scalp Micropigmentation in korea: hair loss and non-hair loss person being centerd. 2022;3:61–73. [Google Scholar]
  • 15.Traquina AC. Micropigmentation as an adjuvant in cosmetic surgery of the scalp. Dermatol Surg. 2001;27:123–128. [PubMed] [Google Scholar]
  • 16.Kim EK, Chang TJ, Hong JP, Koh KS. Use of tattooing to camouflage various scars. Aesthetic Plast Surg. 2011;35:392–395. doi: 10.1007/s00266-011-9698-8. [DOI] [PubMed] [Google Scholar]
  • 17.Park JH, You SH, Kim N. Shaved hair style scalp medical tattooing technique for treatment of advanced male pattern baldness patients. Int J Dermatol. 2019;58:103–107. doi: 10.1111/ijd.14295. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Data 1

Full questionnaire on SMP

ad-37-357-s001.doc (903KB, doc)
Supplementary Table 1

Survey responses from participants with prior SMP experience (n=5)

ad-37-357-s002.xls (32.5KB, xls)
Supplementary Table 2

Reported costs and willingness to pay for SMP among recipients (n=5)

ad-37-357-s003.xls (29KB, xls)
Supplementary Fig. 1

Age and sex distribution of the scalp micropigmentation recipients.

ad-37-357-s004.ppt (208.5KB, ppt)
Supplementary Fig. 2

Legal awareness of tattooing and semi-permanent procedures performed outside medical institutions among scalp micropigmentation recipients.

ad-37-357-s005.ppt (217KB, ppt)

Articles from Annals of Dermatology are provided here courtesy of Korean Dermatological Association and Korean Society for Investigative Dermatology

RESOURCES